-
Arsenal seek to ramp up heat on Man City in title race
-
PSG closing in on another French title before Bayern second leg
-
Espanyol must stop rot against Real Madrid as Barca eye title
-
Leipzig can book return to Champions League as Bundesliga top-four rivals meet
-
Injuries add to Bath's challenge for Champions Cup semi in Bordeaux
-
Karius getting 'back to the top' with promotion-chasing Schalke
-
King Charles arrives in Bermuda after whirlwind US visit
-
Clashes erupt in Australian town over death of Indigenous girl
-
Iran war redraws sea routes with Africa as the pivot
-
India's cows offer biogas alternative to Mideast energy crunch
-
Afghans celebrate spring in bright red poppy fields
-
Finland's 'Flamethrower' and 4 other Eurovision favourites
-
Crude edges up after wild swing, stocks track Wall St rally
-
Eurovision: 70 years of geopolitics, patriotism, music and glitter
-
Knicks demolish Hawks to advance in NBA playoffs
-
Blockbuster EU-Mercosur trade deal enters into force
-
'Uncharted': US court ruling shakes up battle for Congress
-
Florida executes man who spent nearly 50 years on death row
-
Ace lifts rookie Green to share of LPGA lead as Korda lurks
-
Wear a bulletproof vest? I don't want to look fat, says Trump
-
World No. 4 Young leads at PGA Cadillac Championship
-
FIFA to review ticket strategy for 2030 World Cup
-
Bucks hire ex-Grizzlies coach Jenkins
-
Japanese tennis trailblazer Nishikori to retire at end of season
-
Palestinian football chief slams Israeli official at FIFA meeting
-
Britney Spears formally charged with DUI in California
-
Rayo grab lead over Strasbourg in Conference League semi
-
New Princess Diana documentary promises her own words
-
Villa boss Emery fumes as Forest star Anderson escapes red card
-
Oil slumps after hitting peak, US indices reach new records
-
Trump says lifting Scottish whisky tariffs to 'honor' King Charles
-
Venezuela leader hikes minimum wage package by 26%
-
PGA Tour golfers take wait-and-see approach amid LIV turmoil
-
Braga strike late to seize advantage over Freiburg in Europa League semi
-
Miami GP could be moved up as thunderstorms threaten - drivers
-
Apple earnings beat forecasts on iPhone 17 demand
-
Crystal Palace beat Shakhtar to close in on Conference League final
-
Wood punishes Digne blunder as Forest earn Europa semi-final lead against Villa
-
Formula One drivers welcome rule tweaks, but say more change needed
-
Bangladesh signs biggest-ever plane deal for 14 Boeings
-
Musk grilled on AI profits at OpenAI trial
-
Venezuela opens arms to world with Miami-Caracas flight
-
King Charles experiences small-town America on last day of visit
-
Trump mulls US troop cuts in Italy, Spain over Iran row
-
Israel says detained Gaza flotilla activists to be taken to Greece
-
Infantino confirms Iran will play World Cup games in US
-
Blow for Lula as Brazil MPs slash Bolsonaro prison term
-
At Iranian film's Berlin premiere, calls not to forget Iranian people
-
Honda confident Aston Martin power unit problems solved
-
Abuse of retired Bright 'too much', says Chelsea's Bompastor
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
N.Walker--AT